azathioprine has been researched along with Thyroid Diseases in 5 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Thyroid Diseases: Pathological processes involving the THYROID GLAND.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The usual onset of type 1 autoimmune hepatitis occurs at puberty or around menopause, whereas disease presentation in the advanced age is less often reported." | 1.33 | Clinical features of type 1 autoimmune hepatitis in elderly Italian patients. ( Bianchi, FB; Cassani, F; Ferri, S; Granito, A; Lenzi, M; Muratori, L; Muratori, P; Pappas, G, 2005) |
| "Ocular myasthenia gravis is a subtype of myasthenia gravis that causes relatively mild disability, but may convert into severe generalised muscle weakness." | 1.30 | Ocular myasthenia gravis: response to long-term immunosuppressive treatment. ( Dichgans, J; Herzau, V; Melms, A; Schepelmann, K; Sigg, B; Sommer, N; Weller, M, 1997) |
| "Thymoma was more common in the older population; these patients did no worse than the population as a whole." | 1.28 | The relationship of age to outcome in myasthenia gravis. ( Ansher, M; Donaldson, DH; Horan, S; Ringel, SP; Rutherford, RB, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Granito, A | 1 |
| Muratori, L | 1 |
| Pappas, G | 1 |
| Muratori, P | 1 |
| Ferri, S | 1 |
| Cassani, F | 1 |
| Lenzi, M | 1 |
| Bianchi, FB | 1 |
| Sommer, N | 1 |
| Sigg, B | 1 |
| Melms, A | 1 |
| Weller, M | 1 |
| Schepelmann, K | 1 |
| Herzau, V | 1 |
| Dichgans, J | 1 |
| Donaldson, DH | 1 |
| Ansher, M | 1 |
| Horan, S | 1 |
| Rutherford, RB | 1 |
| Ringel, SP | 1 |
| Lavergne, G | 1 |
| Winand, R | 1 |
| Hokkanen, E | 1 |
5 other studies available for azathioprine and Thyroid Diseases
| Article | Year |
|---|---|
Clinical features of type 1 autoimmune hepatitis in elderly Italian patients.
Topics: Adult; Age Distribution; Aged; Aged, 80 and over; Antibodies, Antinuclear; Autoimmune Diseases; Azat | 2005 |
Ocular myasthenia gravis: response to long-term immunosuppressive treatment.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Autoimmune Diseases; Azathioprine; Child; Drug Administr | 1997 |
The relationship of age to outcome in myasthenia gravis.
Topics: Adrenal Cortex Hormones; Aged; Aging; Antibodies; Autoimmune Diseases; Azathioprine; Combined Modali | 1990 |
[Endocrine exophthalmos].
Topics: Adolescent; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Adult; Aged; Animals; Azathioprine | 1973 |
Myasthenia gravis. A clinical analysis of the total material from Finland with special reference to endocrinological and neurological disorders.
Topics: Age Factors; Ambenonium Chloride; Azathioprine; Cortisone; Diabetes Complications; Disability Evalua | 1969 |